The increased use of CSTDs in recent years has revealed a range of complications for both drug developers and end users. High forces, coring and fragmentation, device and vial leakage, high residual volume, and drug physicochemical incompatibilities with commercially available CSTDs are common complaints. Carefully evaluating the compatibility of components with CSTDs is therefore critical.